Japan approves Pfizer–BioNTech vaccine for children aged 12 to 15
The Japanese government approved the Pfizer–BioNTech COVID-19 vaccine for children aged 12 to 15, marking the first vaccine authorised for this age group in the country. The approval followed a clinical trial showing 100% efficacy in preventing symptoms.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthJapan approves Pfizer–BioNTech vaccine for children aged 12 to 15
Sign in or subscribeBrowse free archive reportsThe Japanese government approved the Pfizer–BioNTech COVID-19 vaccine for children aged 12 to 15, marking the first vaccine authorised for this age group in the country. The approval followed a clinical trial showing 100% efficacy in preventing symptoms.